| pubmed-article:21491995 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21491995 | lifeskim:mentions | umls-concept:C0026447 | lld:lifeskim |
| pubmed-article:21491995 | lifeskim:mentions | umls-concept:C1299003 | lld:lifeskim |
| pubmed-article:21491995 | lifeskim:mentions | umls-concept:C0025519 | lld:lifeskim |
| pubmed-article:21491995 | lifeskim:mentions | umls-concept:C0040287 | lld:lifeskim |
| pubmed-article:21491995 | lifeskim:mentions | umls-concept:C0220927 | lld:lifeskim |
| pubmed-article:21491995 | lifeskim:mentions | umls-concept:C0184959 | lld:lifeskim |
| pubmed-article:21491995 | lifeskim:mentions | umls-concept:C1451502 | lld:lifeskim |
| pubmed-article:21491995 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:21491995 | pubmed:dateCreated | 2011-6-13 | lld:pubmed |
| pubmed-article:21491995 | pubmed:abstractText | To investigate the metabolism of a new antiglaucoma difluoroprostaglandin, tafluprost, in ocular tissues and evaluate the distribution of the parent drug and its metabolites in ocular and systemic tissues after a single ocular administration to cynomolgus monkeys (Macaca fascicularis). | lld:pubmed |
| pubmed-article:21491995 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21491995 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21491995 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21491995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21491995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21491995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21491995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21491995 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21491995 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21491995 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:21491995 | pubmed:issn | 1557-7732 | lld:pubmed |
| pubmed-article:21491995 | pubmed:author | pubmed-author:KawazuKouichi... | lld:pubmed |
| pubmed-article:21491995 | pubmed:author | pubmed-author:AkaishiTakahi... | lld:pubmed |
| pubmed-article:21491995 | pubmed:author | pubmed-author:BezwadaPadmaP | lld:pubmed |
| pubmed-article:21491995 | pubmed:author | pubmed-author:PellinenPertt... | lld:pubmed |
| pubmed-article:21491995 | pubmed:author | pubmed-author:FukanoYasufum... | lld:pubmed |
| pubmed-article:21491995 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21491995 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:21491995 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21491995 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21491995 | pubmed:pagination | 251-9 | lld:pubmed |
| pubmed-article:21491995 | pubmed:dateRevised | 2011-10-17 | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:meshHeading | pubmed-meshheading:21491995... | lld:pubmed |
| pubmed-article:21491995 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21491995 | pubmed:articleTitle | Metabolism and ocular tissue distribution of an antiglaucoma prostanoid, tafluprost, after ocular instillation to monkeys. | lld:pubmed |
| pubmed-article:21491995 | pubmed:affiliation | Research and Development Center, Santen Pharmaceutical Co., Ltd., Ikoma-shi, Nara, Japan. yasufumi.fukano@santen.co.jp | lld:pubmed |
| pubmed-article:21491995 | pubmed:publicationType | Journal Article | lld:pubmed |
